Mersana Therapeutics Inc MRSN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:32 PM EDT
2.57UNCH (UNCH)
Volume
32,621
Close
2.57quote price arrow down-0.04 (-1.53%)
Volume
1,856,967
52 week range
0.80 - 9.62
Loading...
  • Open2.68
  • Day High2.88
  • Day Low2.51
  • Prev Close2.61
  • 52 Week High9.62
  • 52 Week High Date06/12/23
  • 52 Week Low0.80
  • 52 Week Low Date07/27/23

Key Stats

  • Market Cap314.468M
  • Shares Out122.36M
  • 10 Day Average Volume2.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change10.78

KEY STATS

  • Open2.68
  • Day High2.88
  • Day Low2.51
  • Prev Close2.61
  • 52 Week High9.62
  • 52 Week High Date06/12/23
  • 52 Week Low0.80
  • 52 Week Low Date07/27/23
  • Market Cap314.468M
  • Shares Out122.36M
  • 10 Day Average Volume2.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change10.78

RATIOS/PROFITABILITY

  • EPS (TTM)-1.14
  • P/E (TTM)-2.26
  • Fwd P/E (NTM)-3.88
  • EBITDA (TTM)-132.536M
  • ROE (TTM)-292.19%
  • Revenue (TTM)38.298M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-352.01%
  • Debt To Equity (MRQ)90.43%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Mersana Therapeutics Inc

 

Profile

MORE
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on the development of antibody-drug conjugates (ADCs), which offer a clinically meaningful benefit for cancer patients with significant unmet needs. It has developed two proprietary and differentiated ADC platforms: Dolasynthen and Immunosynthen. Dolasynthen is its cytotoxic ADC platform that is designed to generate site-specific, homogeneous ADCs. Immunosynthen is its proprietary...
David Mott
Independent Chairman of the Board
Martin Huber M.D.
President, Chief Executive Officer, Director
Brian Deschuytner
Chief Financial Officer, Chief Operating Officer, Senior Vice President
Ashish Mandelia
Chief Accounting Officer, Vice President
Address
840 Memorial Dr
Cambridge, MA
02139-3789
United States

Top Peers

SYMBOLLASTCHG%CHG
CRBU
Caribou Biosciences Inc
3.64UNCHUNCH
RNAC
Cartesian Therapeutics Inc
26.65+1.90+7.68%
FHTX
Foghorn Therapeutics Inc.
5.29-0.38-6.70%
MGTX
MeiraGTx Holdings PLC
5.53+0.30+5.74%
MGNX
MacroGenics Inc
4.71+0.26+5.84%